PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Cardiovascular Electrophysiology10.1111/jce.12546201425121411-1418Oral Anticoagulant Use Around the Time of Atrial Fibrillation Ablation: A Review of the Current Evidence of Individual Oral Anticoagulant Use for Periprocedural Atrial Fibrillation Ablation Thromboembolic ProphylaxisALEX B. GARTON, JOHN DUDZINSKI, PETER R. KOWEYhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjce.12546, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjce.12546, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jce.12546/fullpdf
Therapeutics and Clinical Risk Management10.2147/tcrm.s301592014197Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillationAlexander G G Turpiehttps://www.dovepress.com/getfile.php?fileID=19391
Health Services Research10.1111/1475-6773.130792018541128-138Guidelineā€concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part DNicolae Done, Amanda M. Roy, Yingzhe Yuan, Steven D. Pizer, Adam J. Rose, Julia C. Prenticehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1475-6773.13079, https://onlinelibrary.wiley.com/doi/pdf/10.1111/1475-6773.13079, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/1475-6773.13079, https://onlinelibrary.wiley.com/doi/pdf/10.1111/1475-6773.13079
Value in Health10.1016/j.jval.2019.04.037201922S38-S39CV4 BUDGET IMPACT OF CHANGING ORAL ANTICOAGULANT PRESCRIBING TO PREVENT ATRIAL-FIBRILLATION-RELATED STROKE IN ENGLANDA. Orlowski, J.H. Wu, J. Wilkins, W. Smithhttps://api.elsevier.com/content/article/PII:S1098301519302293?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301519302293?httpAccept=text/plain
Value in Health10.1016/j.jval.2019.04.548201922S139PCV113 DIFFERENCE-IN-DIFFERENCES ANALYSIS OF THE IMPACT OF ORAL ANTICOAGULANT PRESCRIBING ON INCIDENCE OF ATRIAL-FIBRILLATION-RELATED STROKEA. Orlowski, J.H. Wu, J. Wilkins, W. Smithhttps://api.elsevier.com/content/article/PII:S1098301519307405?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301519307405?httpAccept=text/plain
Journal of Stroke and Cerebrovascular Diseases10.1016/j.jstrokecerebrovasdis.2020.1054742021302105474Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial FibrillationHope Hua, Nicole Sur, Lilly Lee, Seemant Chaturvedihttps://api.elsevier.com/content/article/PII:S1052305720308922?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1052305720308922?httpAccept=text/plain
Journal of Stroke10.5853/jos.2020.034402021231113-123Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related StrokeMi-Yeon Eun, Jae-Young Kim, Yang-Ha Hwang, Man-Seok Park, Joon-Tae Kim, Kang-Ho Choi, Jin-Man Jung, Sungwook Yu, Chi Kyung Kim, Kyungmi Oh, Tae-Jin Song, Yong-Jae Kim, Bum Joon Kim, Sung Hyuk Heo, Kwang-Yeol Park, Jeong-Min Kim, Jong-Ho Park, Jay Chol Choi, Jong-Won Chung, Oh Young Bang, Gyeong-Moon Kim, Woo-Keun Seohttp://j-stroke.org/upload/pdf/jos-2020-03440.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2020.03440, http://j-stroke.org/upload/pdf/jos-2020-03440.pdf
BMJ10.1136/bmj.j53992017j5399Which anticoagulant for stroke prevention in atrial fibrillation?Jocasta Ballhttp://data.bmj.org/tdm/10.1136/bmj.j5399, https://syndication.highwire.org/content/doi/10.1136/bmj.j5399
Journal of Stroke10.5853/jos.2016.011022017192232-235Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial FibrillationLester Y. Leung, Mark McAllister, Magdy Selim, Marc Fisherhttp://j-stroke.org/upload/pdf/jos-2016-01102.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2016.01102, http://www.j-stroke.org/upload/pdf/jos-2016-01102.pdf
Atrial Fibrillation Therapy10.1007/978-1-4471-5475-4_3201355-89Novel Oral Anticoagulants for Stroke Prevention in Patients with Non-valvular Atrial FibrillationYoseph Rozenman, Yuri Gluzmanhttp://link.springer.com/content/pdf/10.1007/978-1-4471-5475-4_3